EV

About

Endeavour Vision is a private equity firm investing in growth-stage MedTech and digital health companies. The company invests in medical innovation that provides superior clinical benefits for patients or brings significant efficiencies to health systems. Endeavour Vision team offers strategic and operational expertise and extensive international experience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Vertiflex (acquired by Boston Scientific in 2019), Medartis (IPO on SIX in Q1 2018), and Symetis (acquired by Boston Scientific in 2017). Endeavour Vision’s offices are located in Geneva, Switzerland, and Minneapolis, U.S.

Position in the VCSift Database

  • 33,888 investors in VCSift focus on the fintech sector.
  • 284 investors are based in Geneva, Geneve, Switzerland.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

in••••@endeavourvision.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Endeavour

Search Investors